2 Top Biotech Stocks to Buy Right Now
It's been a rough year for the biotech industry, which as a whole has substantially lagged the broader market. Just look at the performance of the SPDR S&P Biotech ETF, an industry benchmark. What's more, some biotechs have been encountering their own company-specific issues.
Two worth a closer look today are Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA) whose prospects really don't look as bad as their year-to-date performances suggest. At current levels, both Amgen and Moderna are worth investing in now. Let's find out why.
Source Fool.com
Amgen Inc. Stock
€280.85
0.950%
The stock is an absolute favorite of our community with 24 Buy predictions and no Sell predictions.
With a target price of 296 € there is a slightly positive potential of 5.39% for Amgen Inc. compared to the current price of 280.85 €.
